ENDRA Life Sciences Inc. — Form SCHEDULE 13D
Filed October 8, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 42/100
What the filing says
ASP Isotopes, Inc. and LHE LNG Holdings LLC entered into a joint filing agreement on October 8, 2026, permitting coordinated SEC filings under Sections 13 and 16 of the Exchange Act. Both entities are signed by Donald G. Ainscow as Executive Vice President, General Counsel and Secretary, indicating common control. The agreement remains in effect until revoked in writing by any party.
Why this rating
Joint filing agreement suggests coordinated beneficial ownership disclosure, potentially indicating a significant stake acquisition or control change. For a $2.7M market-cap company, even modest ownership concentration matters, but the filing itself is procedural boilerplate without disclosed transaction size, share count, or dollar amounts.
See more from October 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.